Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Cytokinetics
(NQ:
CYTK
)
18.73
USD
-1.12 (-5.64%)
Official Closing Price
Updated: 4:52 PM EST, Feb 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Cytokinetics
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 26, 2021
From
GlobeNewswire News Releases
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
February 26, 2021
From
GlobeNewswire News Releases
Cytokinetics Inc (CYTK) Q4 2020 Earnings Call Transcript
February 26, 2021
CYTK earnings call for the period ending December 31, 2020.
Tags
Market News
CYTK
From
Motley Fool
Cytokinetics Reports Fourth Quarter 2020 Financial Results
February 25, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
JAZZ
AERI
AKBA
From
Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ...
Tags
PODD
ADMS
Market News
From
Benzinga
Cytokinetics Names Muna Bhanji to Board of Directors
February 18, 2021
Appointment Adds to Board Expertise in Commercial Development and Market Access as Company Prepares for Further Corporate Development
From
GlobeNewswire News Releases
Cytokinetics to Announce Fourth Quarter Results on February 25, 2021
February 11, 2021
From
GlobeNewswire News Releases
Cytokinetics Announces Recipients of Third Annual Communications Fellowship Grants
February 02, 2021
Total of $100,000 Awarded to Five Organizations to Support Communications and Community Outreach
From
GlobeNewswire News Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 01, 2021
From
GlobeNewswire News Releases
Cytokinetics Announces First Patient Dosed in Cohort 2 of Redwood-HCM
January 13, 2021
Company Earns $2.5 Million Milestone Payment from Ji Xing Pharmaceuticals
From
GlobeNewswire News Releases
Cytokinetics Granted Orphan Drug Designation for CK-3773274 for the Treatment of Hypertrophic Cardiomyopathy
January 11, 2021
From
GlobeNewswire News Releases
Cytokinetics to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
January 06, 2021
From
GlobeNewswire News Releases
CYTK Makes Notable Cross Below Critical Moving Average
January 04, 2021
In trading on Monday, shares of Cytokinetics Inc (CYTK) crossed below their 200 day moving average of $19.73, changing hands as low as $19.40 per share. Cytokinetics Inc shares are currently trading...
Tags
Stocks
From
Market News Video
Cytokinetics Regains European Rights to Omecamtiv Mecarbil
December 23, 2020
Company is Planning Regulatory Interactions in 2021 to Discuss Results of GALACTIC-HF and Expects to Evaluate Strategic Options for Co-Commercialization and Licensing
From
GlobeNewswire News Releases
Cytokinetics Announces Data and Trial Design Presented at the International Symposium on ALS/MND
December 14, 2020
Additional Data from FORTITUDE-ALS Support Rationale and Design for COURAGE-ALS, A Planned Phase 3 Clinical Trial of Reldesemtiv in Patients with ALS
From
GlobeNewswire News Releases
71 Biggest Movers From Yesterday
December 10, 2020
Gainers Greenwich Lifesciences Inc (NASDAQ: GLSI) shares jumped 998.1% to close at $57.10 on Wednesday after the company reported ...
Tags
NINE
GBIO
LMPX
From
Benzinga
Cytokinetics Announces Progression of REDWOOD-HCM to Cohort 2
December 09, 2020
Interim Analysis of Data from Cohort 1 Demonstrate Substantial Effects of CK-274 to Reduce LVOT Gradient in Patients with Obstructive Hypertrophic Cardiomyopathy with No Dose Interruptions Due to Left...
From
GlobeNewswire News Releases
Cytokinetics Announces Additional Results From GALACTIC-HF Presented at the 17th Global Cardiovascular Clinical Trialists
December 07, 2020
From
GlobeNewswire News Releases
Cytokinetics Announces Three Presentations at the International Symposium on ALS/MND
December 03, 2020
From
GlobeNewswire News Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
December 01, 2020
From
GlobeNewswire News Releases
Cytokinetics Announces Additional Results From GALACTIC-HF to be Presented at the 17th Global Cardiovascular Clinical Trialists Forum
December 01, 2020
Data from Supplemental Analyses to be Shared at Clinical Trials Think Tank Meeting
From
GlobeNewswire News Releases
Cytokinetics to Participate in Upcoming Investor Conferences
November 24, 2020
From
GlobeNewswire News Releases
Cytokinetics Regains Rights to Develop and Commercialize Omecamtiv Mecarbil and AMG 594 From Amgen
November 23, 2020
From
GlobeNewswire News Releases
Wall Street Analysts Say These 5 Stocks Are A Buy As The World Prepares For The Post-COVID-19 Era
November 23, 2020
From escalating tensions between the U.S. and China, the highly infectious coronavirus pandemic outbreak, and the 2020 presidential ...
Tags
Long Ideas
e/commerce
Analyst Ratings
From
Benzinga
Cytokinetics Names Nancy Wysenski to Board of Directors
November 20, 2020
Appointment Strengthens Commercial, Market Access and Specialty Sales Expertise as Company Advances Pipeline Toward Potential Commercialization
From
GlobeNewswire News Releases
Cytokinetics Announces Presentations Related to Health Economics and Outcomes Research in Heart Failure and Hypertrophic Cardiomyopathy at the AHA Scientific Sessions 2020
November 16, 2020
From
GlobeNewswire News Releases
Cytokinetics Announces Preclinical Data for CK-3773274 and CK-3772271 Presented at the AHA Scientific Sessions 2020
November 16, 2020
New Findings from Studies of Cardiac Myosin Inhibitors in Animal Models of Hypertrophic Cardiomyopathy and Heart Failure with Preserved Ejection Fraction
From
GlobeNewswire News Releases
Cytokinetics Announces Results From GALACTIC-HF Presented at Late Breaking Clinical Trial Session at the American Heart Association Scientific Sessions and Published in the New England Journal of Medi
November 13, 2020
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
November 13, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Biotech
AMGN
DRRX
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.